Activated Recombinant Human Factor VII

Factor VIIa · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Activated Recombinant Human Factor VII, covering 2017-01-11 to 2023-12-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery [Phase 4]

See pricing